1. Home
  2. BSX vs BUD Comparison

BSX vs BUD Comparison

Compare BSX & BUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSX
  • BUD
  • Stock Information
  • Founded
  • BSX 1979
  • BUD 1366
  • Country
  • BSX United States
  • BUD Belgium
  • Employees
  • BSX N/A
  • BUD N/A
  • Industry
  • BSX Medical/Dental Instruments
  • BUD Beverages (Production/Distribution)
  • Sector
  • BSX Health Care
  • BUD Consumer Staples
  • Exchange
  • BSX Nasdaq
  • BUD Nasdaq
  • Market Cap
  • BSX 138.4B
  • BUD 136.1B
  • IPO Year
  • BSX 1992
  • BUD N/A
  • Fundamental
  • Price
  • BSX $104.94
  • BUD $69.32
  • Analyst Decision
  • BSX Strong Buy
  • BUD Strong Buy
  • Analyst Count
  • BSX 22
  • BUD 4
  • Target Price
  • BSX $112.86
  • BUD $72.00
  • AVG Volume (30 Days)
  • BSX 8.1M
  • BUD 2.5M
  • Earning Date
  • BSX 07-23-2025
  • BUD 07-31-2025
  • Dividend Yield
  • BSX N/A
  • BUD 1.22%
  • EPS Growth
  • BSX 15.23
  • BUD 45.11
  • EPS
  • BSX 1.37
  • BUD 3.38
  • Revenue
  • BSX $17,554,000,000.00
  • BUD $58,849,000,000.00
  • Revenue This Year
  • BSX $17.50
  • BUD $1.98
  • Revenue Next Year
  • BSX $10.75
  • BUD $4.52
  • P/E Ratio
  • BSX $76.45
  • BUD $20.47
  • Revenue Growth
  • BSX 19.36
  • BUD N/A
  • 52 Week Low
  • BSX $71.88
  • BUD $45.94
  • 52 Week High
  • BSX $107.53
  • BUD $72.13
  • Technical
  • Relative Strength Index (RSI)
  • BSX 65.40
  • BUD 47.62
  • Support Level
  • BSX $100.90
  • BUD $67.97
  • Resistance Level
  • BSX $107.53
  • BUD $69.43
  • Average True Range (ATR)
  • BSX 1.56
  • BUD 0.69
  • MACD
  • BSX 0.68
  • BUD -0.45
  • Stochastic Oscillator
  • BSX 92.03
  • BUD 29.33

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)

Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.

Share on Social Networks: